The increasing number of bacterial infections globally that do not respond to any available
antibiotics indicates a need to invest in—and ensure access to—new antibiotics, vaccines …

Sexually transmitted infections (STIs) pose a global health threat. Most of these infections
are curable if detected in a timely and accurate manner. In 2022, the World Health …

Point-of-care testing (POCT) holds significant importance in the field of infectious disease
prevention and control, as well as personalized precision medicine. The emerging …

HIV self-testing, which has been increasingly available since 2016, can substantially
enhance the uptake of HIV testing, especially for key populations. Clinical trials have …

Background Neisseria gonorrhoeae (NG) has acquired significant resistance, primarily due
to extensive and unwarranted antibiotic utilization over several decades. This resistance has …

Nucleic acid amplification testing (NAAT) for N. gonorrhoeae is unavailable in resource-
limited settings. We previously developed a CRISPR-based lateral flow assay for detecting …

Antimicrobial resistance (AMR), a huge global health threat, will be back in the spotlight
when the UN will conduct a second high-level meeting on AMR in September, 2024. Ahead …

At least one million curable sexually transmitted infections (STIs) are acquired daily, and
their long-term consequences affect reproductive health, psychological health, neonatal …

Background Diagnosis of Neisseria (N.) gonorrhoeae is dependent on nucleic acid
amplification testing (NAAT), which is not available in resource-limited settings where the …

Chlamydia trachomatis (C. trachomatis) is a common sexually transmitted infection (STI). In
2019, the World Health Organization reported about 131 million infections. The majority of …